於晶

副研究員

  • 電話:+86-021-34207401
  • 郵箱🔧:jingyu@sjtu.edu.cn
  • 研究工作主要專註於針對重要疾病的藥物靶點,進行特異靶向藥效新分子的發現、分析及其作用機製的研究🍫🧜🏻,以及藥物遞送的研究。作為第一(或共第一)或共同通訊作者🥇,已連續在本領域的權威期刊上發表原創科研論文多篇📁,發表論文得到了國際同行的積極評價🧑🏽‍⚖️;同時,申請和得到授權國內外專利多項👩🏽‍🎓。

學術經歷

  • 2002.08 - 現在           EON体育4👨‍👨‍👧‍👦,EON体育4平台
  • 2008.06 –2010.08      瑞士日內瓦大學🤸🏽‍♀️,藥學系🌨,博士後
  • 2005.01 - 2008.05      瑞士巴塞爾大學,藥學系,博士
  • 2000.07 - 2002.07      沈陽藥科大學/中國科EON4上海生物工程研究中心,碩士
  • 1996.09 - 2000.06      沈陽藥科大學/吉林大學🕵🏻,學士,生物技術製藥(本碩六年班)

研究方向

生物大分子及藥用小分子的藥物遞送研究

生物大分子及藥用小分子的藥物遞送研究

針對重要疾病的藥物靶點,進行特異靶向藥效新分子的發現...

針對重要疾病的藥物靶點🩼,進行特異靶向藥效新分子的發現、分析及其作用機製的研究

代表論著

  • •  

    Gang Xiang, Shuxuan Wang, Ling Chen, Mei Song, Xiaoxu Song, Huan Wang, Pengbo Zhou, Xiaojing Ma*, Jing Yu*, UBR5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer, Cell Death and Disease, 13(2022), 451.

    •  

    Fan Liu#, Jing Yu#, Yan-Xia Zhang, Fangzheng Li, Qi Liu, Yueyang Zhou, Shengshuo Huang, Houqin Fang, Zhuping Xiao, Lujian Liao, Jinyi Xu, Xin-Yan Wu, Fang Wu*. High-throughput tandem-microwell assay for ammonia repositions FDA-Approved drugs to inhibit Helicobacter pylori urease. FASEB journal, 35 (2021), 21967.

    •  

    Giorgia Croppi, Yueyang Zhou, Rong Yang, Yunfei Bian, Mingtao Zhao, Youtian Hu, Benfang Helen Ruan, JingYu*, FangWu*, Discovery of an Inhibitor for Bacterial 3-Mercaptopyruvate Sulfurtransferase that Synergistically Controls Bacterial Survival, Cell chemical biology, 27 (2020), 1483-1499.

    •  

    Rezvan Moallemian, Ashfaq Ur. Rahman, Na Zhao, Huan Wang, Haifeng Chen, Gang Lin, Xiaojing Ma*, Jing Yu*, Immunoproteasome inhibitor DPLG3 attenuates experimental colitis by restraining NF-κB activation, Biochemical pharmacology, 177 (2020), 113964.

    •  

    Youtian Hu#, Lu Wang#, Xu Han, Yueyang Zhou, Tonghui Zhang, Li Wang, Ting Hong, Wei Zhang, Xun-Xiang Guo, Jielin Sun, Yingxing Qi, Jing Yu*, Hong Liu*, and Fang Wu*, Discovery of a Bioactive Inhibitor with a New Scaffold for Cystathionine gamma-Lyase, Journal of medicinal chemistry, (2019) DOI: 10.1021/acs.jmedchem.8b01720 • Publication Date (Web): 18 Dec 2018.

  • •  

    Li Wang#, Hao Cai#, Youtian Hu, Fan Liu, Shengshuo Huang, Yueyang Zhou, Jing Yu*, Jinyi Xu* and Fang Wu*✨,A pharmacological probe identifies cystathionine beta-synthase as a new negative regulator for ferroptosis, Cell death & disease, 9 (2018) 1005.

    •  

    Jing Yu, Sachin Dubey and Yogeshvar N. Kalia*, Needle-free cutaneous delivery of living human cells by Er:YAG fractional laser ablation, Expert opinion on drug delivery, 15 (2018) 559-566.

    •  

    Zhixue Du#, Jing Yu#, Fucai Li, Liyun Deng, Fang Wu, Xiangyi Huang, Jan Bergstrand, Jerker Widengren, Chaoqing Dong* and Jicun Ren*, In Situ Monitoring of p53 Protein and MDM2 Protein Interaction in Single Living Cells Using Single-Molecule Fluorescence Spectroscopy, Analytical chemistry, 90 (2018) 6144-6151.

    •  

    Yueyang Zhou#, Jing Yu#, Xiling Lei, Jianying Wu, Qi Niu, Yixuan Zhang, Hong Liu, Philipp Christen, Heinz Gehringe and Fang Wu*, High-throughput tandem-microwell assay identifies inhibitors of the hydrogen sulfide signaling pathway, Chemical communications, 49 (2013) 11782-11784.

    •  

    Jing Yu, Dhaval R. Kalaria, Yogeshvar N. Kalia*, Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies, Journal of controlled release, 156 (2011) 53-59.

獲獎情況

  • 在2007年,作為兩名中的一名🧑🏿‍⚕️⬅️,代表瑞士參加了英國牛津大學舉辦的第二屆EMBO蛋白質高效製備和結晶的課程,並獲得該課程中的唯一獎項“學術海報獎”第一名。
EON体育4平台专业提供😀:EON体育4平台🦸🏼‍♀️、EON体育4EON体育4登录等服务,提供最新官网平台、地址、注册、登陆、登录、入口、全站、网站、网页、网址、娱乐、手机版、app、下载、欧洲杯、欧冠、nba、世界杯、英超等,界面美观优质完美,安全稳定,服务一流🤫,EON体育4平台欢迎您。 EON体育4平台官網xml地圖